King Hussein Cancer Center
Clinical trials sponsored by King Hussein Cancer Center, explained in plain language.
-
New CAR T-Cell therapy targets tough lymphoma cases
Disease control Recruiting nowThis study tests a single dose of a new cell therapy (MB-CART19.1) in 26 adults with a type of blood cancer called non-Hodgkin lymphoma that has come back or not responded to other treatments. The therapy uses the patient's own immune cells, modified to attack cancer cells. Parti…
Phase: PHASE2 • Sponsor: King Hussein Cancer Center • Aim: Disease control
Last updated May 17, 2026 02:34 UTC
-
Can we make cancer-fighting cells at the hospital? new study aims to find out.
Disease control Recruiting nowThis study is testing whether a special type of immune cell therapy (CAR-T cells) can be successfully made right at the hospital for people with B-cell acute lymphoblastic leukemia that has come back or not responded to treatment. The main goal is to see if the manufacturing proc…
Phase: NA • Sponsor: King Hussein Cancer Center • Aim: Disease control
Last updated May 17, 2026 02:33 UTC